2020 Research Awards and Donors

The Crohn's & Colitis Foundation is pleased to acknowledge the following investigators for their excellence in research approaches to advancing our knowledge of IBD.

Investigators

Research Fellowship Award for Research Excellence 

Juan Matute, MD

Massachusetts General Hospital

Boston, MA

The role of Intelectin-1 in intestinal homeostasis


Lloyd Mayer Career Development Award 

Cambrian Liu, PhD

Children’s Hospital Los Angeles

Los Angeles, CA

Squamous cell-mediated colonic wound healing for inflammatory bowel disease

 

North American Society for Pediatric Gastroenterology, Hepatology and Nutrition 
(NASPGHAN)
Career Development Award
 

Cambrian Liu, PhD

Children’s Hospital Los Angeles

Los Angeles, CA

Squamous cell-mediated colonic wound healing for inflammatory bowel disease

 

The Foundation is also pleased to acknowledge the following donors whose gifts were designated in support of individual researcher awards.

Donors

Ethel Wilson Bowles and Robert Bowles Memorial Fund

Uma Mahadevan, MD 

University of California, San Francisco 

San Francisco, CA 

Pregnancy and Inflammatory Bowel Disease And Neonatal Outcomes (PIANO) Registry:
Long-term Outcomes of In-Utero Biologic Exposure


Flowerree Foundation and Roddenberry Foundation

Stephan Targan, MD 

Cedars-Sinai Medical Center

Los Angeles, CA 

A personalized intestinal fibrosis model combining patient specific iPSC-derived human intestinal organoids and small microengineered Chip technology


F.M. Kirby Foundation 

Varun Aggarwala, PhD

Icahn School of Medicine at Mount Sinai

New York, NY

Understanding the strain level dynamics of fecal microbiota transplantation in ulcerative colitis

Lei Zhou, PhD

Joan & Sanford I. Weill Medical College of Cornell University

New York, NY

IL-2-dependent regulation of intestinal health and inflammation


Linda Tallen & David Paul Kane Educational and Research Foundation 

Ronen Sumagin, PhD

Northwestern University

Chicago, IL 

Neutrophil-driven inflammation leads to carcinogenesis in IBD


Leona M. and Harry B. Helmsley Charitable Trust 

The Leona M. and Harry B. Helmsley Charitable Trust has been a visionary supporter of Crohn’s disease research and the Crohn’s & Colitis Foundation, providing significant support in 2020 to IBD Plexus®, IBD Qorus®, and the IBD Help Center (Irwin M. and Suzanne R. Rosenthal IBD Resource Center). The Helmsley Charitable Trust also supported the following awards:

Rana Al-Sadi, PhD 

University of New Mexico 

Albuquerque, NM 

MMP-9 modulates intestinal epithelial tight junction barrier and intestinal inflammation 

Ashwin Ananthakrishnan, MD, PhD 

Massachusetts General Hospital 

Boston, MA 

Microbiome predictors of response to  anti-TNF and anti-integrin therapy in inflammatory bowel diseases 

Jennifer Dotson, MD, MPH 

The Research Institute at Nationwide Children’s Hospital 

Columbus, OH 

The effect of provider bias and patient/family hardships on healthcare disparities in pediatric inflammatory  bowel disease 

Mark Frey, PhD 

Children’s Hospital Los Angeles 

Los Angeles, CA 

Suppression of pro-inflammatory macrophage activity by ErbB4 

Melanie Gareau, PhD 

University of California, Davis 

Davis, CA 

The microbiota-gut-brain axis in pediatric IBD 

 

Shinya Ito, MD 

The Hospital for Sick Children 

Toronto, ON 

Assessing the drug exposure risk of infants breastfed by women with inflammatory bowel disease 

Frits Koning, PhD 

Leiden University Medical Center 

Leiden, Netherlands 

Identification of Crohn’s disease-specific immune signatures through high-resolution multiparameter analysis of the intestinal immune system 

Yelizaveta Konnikova, MD, PhD 

Brigham and Women’s Hospital, Inc. 

Boston, MA 

High dimensional immunophenotyping and functional assessment of intestinal tissue in VEOIBD 

Pawan Kumar, PhD 

Stony Brook University 

Stony Brook, NY 

IL-17 receptor signaling and intestinal host defense 

Sila Kurugol, PhD 

Boston Children’s Hospital 

Boston, MA 

Motion-robust quantitative MR imaging markers for assessment of inflammation and fibrosis in Crohn’s disease

 

Alan Moss, MD

Boston Medical Center

Boston, MA

Intestinal Microbial Therapy to Prevent Endoscopic Crohn’s Disease Recurrence (IMPEDe Trial)

 

Olga Sarmento, PhD 

Mayo Clinic 

Rochester, MN 

EZH2 prevents IBD by silencing critical T cell gene networks responsible for the production ofpathogenic FOXP3+ cells  

Shiyan Yu, PhD 

Rutgers University–Newark 

Newark, NJ 

Role of Paneth cell lysozyme in modulating microbiota colonization and IBD pathogenesis